[1]
Correa, J.P.M.N. et al. 2025. CARDIOVASCULAR RISKS ASSOCIATED WITH THE SYSTEMIC USE OF NAPHAZOLINE: AN INTEGRATIVE REVIEW. Seven Editora. (Dec. 2025), 598–610.